BioMed Transition Partners
Biotechnology ResearchNew York, United States2-10 Employees
BioMed Transition Partners is a biotechnology-focused advisory firm based in New York, New York, that provides leadership and operational guidance to biomedical companies, including hands-on management when requested, to drive change, growth, and shareholder value. Its services are aimed at investors, boards of directors, and management teams seeking assistance with transactions, financings, and liquidity events, as well as strategic guidance to develop life sciences, biotechnology, and specialty pharmaceutical ventures along with related medical devices, diagnostics, and medtech areas. The firm positions itself as experienced in development across company stages and across related fields, leveraging a track record of leading organizations involved in research tools, imaging devices, and biological product lines. Founded and led by industry operating executives, BioMed Transition Partners operates in the biotechnology research sector from its New York base and has continued to add leadership, such as appointing a new partner in 2018. The firm’s activities are geared toward enabling investors and management to pursue value creation through strategic guidance, leadership, and, when appropriate, hands-on management.